Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-028132

Chief Development Officer sold 1,385 shares at $15.01 ($20,789)

  • Chief Development Officer acquired 1,385 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer Chief Development Officer 2022-08-08 Option exercise +1,385 $4.30 $5,956 54,416 D
Michaelson Jennifer Chief Development Officer 2022-08-08 Sale −1,385 $15.01 $20,789 53,031 D
Derivatives
Michaelson Jennifer Chief Development Officer 2022-08-08 Option exercise · Stock Option (Right to Buy) −1,385 208,593 D
Open-market sales · 1,385 sh · avg $15.01 · $20,789
Loading xslF345X03/doc4.xml…